New blood thinning agent approved for GPs in Scotland

Rivaroxaban for DVT and for stroke prevention in AF has been approved by the Scottish Medicines Consortium (SMC), widening treatment options for GPs in Scotland.

by Stephen Robinson

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now Register Now

Take a 30-day trial

  • Join MIMS now and pay nothing for the first 30 days
  • Join GPOnline now and pay nothing for the first 30 days

Sign Up Sign Up